Vaxzevria

Capillary Leak Syndrome – Another Side Effect Of AstraZeneca CoviShield Vaccine

June 12, 2021 10 Comments

The European Medicines Agency’s (EMA) safety committee has added another blood condition to the potential side effects of AstraZeneca’s vaccine branded as Covishield in India – the Capillary Leak Syndrome.

AstraZeneca Changes Its COVID-19 Vaccine Name From CoviShield To Vaxzevria Due To Blood Clots Controversy

April 1, 2021 1 Comment

AstraZeneca has rebranded and changed the name of its COVID-19 vaccine from CoviShield to Vaxzevria. The move is because the company is struggling to convince people that the vaccine is safe amidst the controversy that AstraZeneca COVID-19 vaccine is causing blood clots.

Vaxzevria

Capillary Leak Syndrome – Another Side Effect Of AstraZeneca CoviShield Vaccine

AstraZeneca Changes Its COVID-19 Vaccine Name From CoviShield To Vaxzevria Due To Blood Clots Controversy

get in touch

Follow us

Vaxzevria

Capillary Leak Syndrome – Another Side Effect Of AstraZeneca CoviShield Vaccine

AstraZeneca Changes Its COVID-19 Vaccine Name From CoviShield To Vaxzevria Due To Blood Clots Controversy

get in touch

Follow us

Cookies